If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCranswick Regulatory News (CWK)

Share Price Information for Cranswick (CWK)

Share Price is delayed by 15 minutes
Get Live Data
5,600.00    -40.00 (-0.71%)
Bid:
5,590.00
Ask:
5,610.00
Spread: 20.00 (0.358%)
Market Cap: £3.00b
CWK Live PriceLast checked at - London Stock Exchange

Intraday Cranswick Share Chart

Fourth Quarter Trading Statement

7 Apr 2014 07:00

RNS Number : 1498E
Cranswick PLC
07 April 2014
Β 

ο»Ώ

7 April 2014

Β 

Cranswick plc

("Cranswick" or "the Group" or "the Company")

Β 

Trading statement for the year ended 31 March 2014

Β 

Cranswick plc issues the following update on trading for the year ended 31 March 2014. Cranswick expects to announce its full year results on 19 May 2014.

Β 

Current trading

Β 

Underlying sales increased by 12 per cent in the year ended 31 March 2014.

Β 

Total sales for the year were 13 per cent higher after taking into account the contribution from acquisitions. Strong growth was seen across most product categories, particularly fresh pork, bacon and cooked meats. Pastry sales also continue to grow strongly following the successful launch of several new product ranges during the year. Export sales were well ahead of the levels reported in the previous financial year, reflecting robust demand for pork products in Far Eastern markets.

Β 

The Group invested in excess of Β£20 million in its infrastructure during the year ended 31 March 2014, allowing it to further improve operational efficiencies and to launch new product ranges. The Group's new gourmet pastry facility at Malton, North Yorkshire, was successfully commissioned earlier in the financial year, albeit with higher than anticipated start-up costs and work is ongoing on the extension to the Milton Keynes cooked meats facility which will add substantial capacity and deliver further efficiency gains.

Β 

As previously reported, the record input prices seen during the year impacted operating margins#. Despite some recovery as the year progressed, operating margins# will, as expected, be slightly below those achieved in the previous financial year.

Β 

Financial position

Β 

Notwithstanding the significant capital investment programme and the acquisition of the pig breeding and rearing activities earlier in the year, strong cash generation from operating activities through the final quarter will result in year-end net debt being substantially lower than at the end of quarter three and below the level reported at the last financial year end.

Β 

The Group recently extended the term and increased the size of its banking facility, leaving the business in a sound financial position, with committed, unsecured facilities of Β£120 million which provide generous headroom through to July 2018.

Β 

Outlook

Β 

With experienced management at all levels of the Group, a strong range of products, a well invested asset base and a robust financial position, the Board remains confident in the continued long term success and development of the business.

Β 

Β 

Β 

Enquiries:

Paul Quade 07947 186694

CityRoad Communications 020 7248 8010

Β 

Β 

Β 

Β Notes:

1. Cranswick's activities are focused within the UK and include the breeding and rearing of premium British pigs, together with the processing and supply of fresh pork, sausage, bacon, cooked meats, charcuterie, pastry products and sandwiches. Products are primarily supplied into the UK food retail, food service and food manufacturing sectors. Results for the year to 31 March 2013 showed sales of Β£875m and profit before tax of Β£47.4m.

2. This announcement is based on information sourced from unaudited management accounts.

3. This announcement contains certain forward looking statements with respect to the financial conditions, results of operations and businesses of Cranswick. These statements involve risk and uncertainty because they relate to events and depend upon circumstances that will occur in the future. There are a number of factors that could cause actual results or developments to differ materially from those expressed or implied by these forward looking statements. Nothing in this announcement should be construed as a profit forecast.

Β 

# excluding net IAS 41 valuation movement on biological assets in the current financial year and non-recurring items in both the current and prior financial years

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
TSTQZLFBZZFZBBQ
Date   Source Headline
24th Mar 20253:39 pmRNSDirector/PDMR Shareholding
20th Mar 20257:00 amRNSCMD and upgraded medium term targets
11th Mar 20257:05 amRNSDirectorship
5th Mar 20252:24 pmRNSTotal Voting Rights
3rd Mar 20253:27 pmRNSHolding(s) in Company
24th Feb 20254:54 pmRNSDirector/PDMR Shareholding
10th Feb 20252:51 pmRNSAdditional Listing
3rd Feb 202510:04 amRNSTotal Voting Rights
22nd Jan 20251:21 pmRNSHolding(s) in Company
21st Jan 20257:00 amRNSQ3 Trading Update and Acquisition of JSR Genetics
7th Jan 20254:02 pmRNSTotal Voting Rights
27th Dec 20247:00 amRNSDirector/PDMR Shareholding
11th Dec 20243:26 pmRNSHolding(s) in Company
3rd Dec 20249:53 amRNSTotal Voting Rights
26th Nov 20247:00 amRNSINTERIM RESULTS
13th Nov 202411:41 amRNSTotal Voting Rights
1st Oct 202412:46 pmRNSTotal Voting Rights
1st Oct 202412:43 pmRNSBlock Listing LTIP return
1st Oct 202412:41 pmRNSBLOCK LISTING SIX MONTHLY RETURN
1st Oct 202412:38 pmRNSDirector/PDMR Shareholding
27th Sep 20247:00 amRNSHalf Year Trading Update
25th Sep 20243:19 pmRNSDirector/PDMR Shareholding
16th Sep 202411:56 amRNSHolding(s) in Company
16th Sep 202411:55 amRNSHolding(s) in Company
12th Aug 202412:15 pmRNSDirector/PDMR Shareholding
6th Aug 20244:20 pmRNSDirector/PDMR Shareholding
5th Aug 202412:18 pmRNSDirector/PDMR Shareholding
5th Aug 202412:16 pmRNSDirector/PDMR Shareholding
5th Aug 202412:15 pmRNSDirector/PDMR Shareholding
5th Aug 202412:11 pmRNSDirector/PDMR Shareholding
1st Aug 202410:52 amRNSTotal Voting Rights
29th Jul 20244:02 pmRNSAGM Statement
29th Jul 20247:00 amRNSFirst quarter trading statement
3rd Jun 20249:42 amRNSTotal Voting Rights
21st May 20247:00 amRNSPreliminary Results
15th May 20245:22 pmRNSDirector/PDMR Shareholding
2nd May 20249:26 amRNSTotal Voting Rights
2nd Apr 20241:55 pmRNSBlock listing Interim Review
2nd Apr 20241:54 pmRNSBlock listing Interim Review
2nd Apr 20241:50 pmRNSTotal Voting Rights
27th Mar 20249:58 amRNSDirector/PDMR Shareholding
21st Mar 20241:57 pmRNSDirector/PDMR Shareholding
21st Mar 20241:55 pmRNSDirector/PDMR Shareholding
21st Mar 20247:00 amRNSDirectorate Change
15th Mar 20243:58 pmRNSDirector/PDMR Shareholding
4th Mar 20249:58 amRNSTotal Voting Rights
14th Feb 202410:11 amRNSDirector/PDMR Shareholding
14th Feb 202410:11 amRNSDirector/PDMR Shareholding
2nd Feb 202411:00 amRNSTotal Voting Rights
18th Jan 20247:00 amRNSThird quarter trading statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.